GB202401411D0 - C-domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases - Google Patents

C-domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases

Info

Publication number
GB202401411D0
GB202401411D0 GBGB2401411.0A GB202401411A GB202401411D0 GB 202401411 D0 GB202401411 D0 GB 202401411D0 GB 202401411 A GB202401411 A GB 202401411A GB 202401411 D0 GB202401411 D0 GB 202401411D0
Authority
GB
United Kingdom
Prior art keywords
treatment
cardiovascular diseases
ace
domain
nep compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2401411.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiodesign Uk Ltd
Original Assignee
Angiodesign Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiodesign Uk Ltd filed Critical Angiodesign Uk Ltd
Priority to GBGB2401411.0A priority Critical patent/GB202401411D0/en
Publication of GB202401411D0 publication Critical patent/GB202401411D0/en
Pending legal-status Critical Current

Links

GBGB2401411.0A 2024-02-02 2024-02-02 C-domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases Pending GB202401411D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2401411.0A GB202401411D0 (en) 2024-02-02 2024-02-02 C-domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2401411.0A GB202401411D0 (en) 2024-02-02 2024-02-02 C-domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases

Publications (1)

Publication Number Publication Date
GB202401411D0 true GB202401411D0 (en) 2024-03-20

Family

ID=90236251

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2401411.0A Pending GB202401411D0 (en) 2024-02-02 2024-02-02 C-domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases

Country Status (1)

Country Link
GB (1) GB202401411D0 (en)

Similar Documents

Publication Publication Date Title
HK1068885A1 (en) N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases n--
HK1089376A1 (en) Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions
NZ720946A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
SI2034999T1 (en) Dha esters and use thereof in the treatment and the prevention of cardiovascular diseases
EP1679058A4 (en) Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
IL180992A0 (en) Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis
EP1692305A4 (en) Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
IL179560A0 (en) Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
IL289289A (en) Polyaromatic urea derivatives and their use in the treatment of muscle diseases
GB202401411D0 (en) C-domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases
GB202301266D0 (en) C-domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases
GB202201142D0 (en) C-Domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases
GB202108565D0 (en) C-Domain ACE/NEP compounds and their use in the treatment of cardiovascular diseases
GB202009360D0 (en) C-domain ace/nep compounds and their use in the treatment of cardiovascular diseases
PL3937948T3 (en) Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases
AU2003233681A8 (en) Diagnosis and treatment of human dormancy syndrome
IL179561A0 (en) Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
IL162941A0 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
IL290192A (en) Nitenin analogue compounds and their use in the treatment of chronic and acute pain
AU2003245858A8 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
GB2610895B (en) Composition for use in the treatment and/or prevention of mycotoxic disease
HUP0301451A3 (en) Use of cgmp pde5 inhibitors for the preparation of pharmaceutical compositions treating peripheral vascular diseases, peripheral neuropathies and autonomic neuropathies
IL178300A0 (en) Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease
GB202107297D0 (en) Composition for use in the treatment and/or prevention of mycotoxic disease
GB202305541D0 (en) Novel compounds and their use in therapy